Fintel reports that on August 6, 2025, Wells Fargo upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from ...

A company has been bought by a Lancashire manufacturer in a new deal. Vanguard Vertex has acquired TPCC Holdings Limited, the ...

Forbes Solicitors has advised Vanguard Vertex on the acquisition of TPCC Holdings Limited, which owns subsidiaries The Printed Cup Company and The Paper Cup Company.

Vertex is faced with an access challenge as it is charging $15.50 for a 50 mg dose of Journavx, which works out to $420 for a two-week course. Generic opioids, meanwhile, go for roughly $0.50 a pill.

Vertex Pharmaceuticals VRTX -1.88% has agreed to acquire Alpine Immune Sciences ALPN 0.02% for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue ...

Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of $11.84 billion, according to data compiled by LSEG.

Vertex doesn't pay a dividend at present, which is unusual among the "Big Pharma" sector. However, its stock is up nearly 60% on a five-year basis, and remarkably, up >150% since October 2021.